Tandem Diabetes Care

Tandem Diabetes Care, operating under the aliases Tandem Diabetes Care and Tandem Diabetes, is a United States-based medical technology company focused on diabetes management. The organization develops, manufactures, and supports medical devices and related services for individuals with insulin-dependent diabetes. Its core product portfolio includes sophisticated insulin pump systems designed to provide precise and automated insulin delivery, enhancing therapy management for patients. The company serves a broad market across the United States, distributing its products through healthcare providers, pharmacies, and directly to patients. Its work places it within the highly regulated medical device sector, requiring compliance with stringent standards from agencies like the U.S. Food and Drug Administration. Tandem's business model centers on improving clinical outcomes and quality of life for people with diabetes through technological innovation in insulin delivery.

The scale of Tandem's customer reach is evidenced by the significant number of individuals impacted by a major security incident in January 2020. A phishing attack compromised employee email accounts, potentially exposing the personal and clinical information of approximately 140,000 customers. This data included names, contact details, product usage information, diabetes therapy clinical data, and a limited number of Social Security numbers. The incident underscores the sensitive nature of the health data the company handles. In response, Tandem engaged external cybersecurity experts, secured affected accounts, and implemented a comprehensive remediation plan. This included mailing notification letters, establishing a dedicated support line, and offering credit monitoring services to those whose Social Security numbers were at risk. The company subsequently enhanced its security posture with stricter email authentication protocols, refined email data transfer restrictions, and improved overall email controls to mitigate future risks. These actions highlight a operational focus on data protection and regulatory compliance following a breach of protected health information. The organization remains a recognized entity in the diabetes care space, with its incident response reflecting the responsibilities of a custodian of sensitive patient data within the U.S. healthcare ecosystem.